Details for New Drug Application (NDA): 083221
✉ Email this page to a colleague
NDA 083221 describes PROBENECID W/ COLCHICINE, which is a drug marketed by Lederle and Watson Labs and is included in two NDAs. Additional details are available on the PROBENECID W/ COLCHICINE profile page.
The generic ingredient in PROBENECID W/ COLCHICINE is colchicine; probenecid. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.
The generic ingredient in PROBENECID W/ COLCHICINE is colchicine; probenecid. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.
Summary for 083221
| Tradename: | PROBENECID W/ COLCHICINE |
| Applicant: | Watson Labs |
| Ingredient: | colchicine; probenecid |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG;500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
